Furosemide
NDC 63561-0165, FUROSEMIDE, tablet, from Granulation Technology, Inc..
- Product NDC
- 63561-0165
- Status
- Listed
- Labeler
- Granulation Technology, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA018569
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FUROSEMIDE40 mg/1
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63561-0165-1 | 63561016501 | 100 TABLET in 1 BOTTLE (63561-0165-1) |
| 63561-0165-2 | 63561016502 | 1000 TABLET in 1 BOTTLE (63561-0165-2) |
| 63561-0165-9 | 63561016509 | 90 TABLET in 1 BOTTLE (63561-0165-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/462e8917-cbe0-f4f9-e063-6394a90ab4ffNADAC price for package 63561016502
GET /v1/drugs/nadac/63561016502
Use it
Look up 63561-0165 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63561-0165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.